Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Testosterone Replacement Therapy Market 2019-2023 | Rise in Novel Therapeutic Approaches to Boost Demand | Technavio

Technavio Research
Posted on: 11 Dec 18

The global testosterone replacement therapy market is expected to decelerate at CAGR of over (2%) during the period 2019-2023, according to the latest market research report by Technavio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005655/en/

Technavio has released a new market research report on the global testosterone replacement therapy market for the period 2019-2023. (Graphic: Business Wire)

A key factor driving the growth of the global testosterone replacement therapy market is the initiatives to increase awareness of disease among the population. Increased awareness about hypogonadism among the public and primary care physicians will drive the market. Globally, different organizations are working on initiatives to increase patient awareness of hypogonadism and available treatment options. For instance, companies such as Auxilium Pharmaceuticals initiated a low testosterone awareness campaign in 2011.

This market research report on the global testosterone replacement therapy 2019-2023 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

In this report, Technavio highlights the rise in novel therapeutic approaches as one of the key emerging trends in the global testosterone replacement therapy market:

Global testosterone replacement therapy market: Rise in novel therapeutic approaches

The market has witnessed a rise in novel therapeutic approaches to treat low testosterone deficiency. Metabolic syndrome can lead to testosterone deficiency. Metabolic syndrome is treated with anti-inflammatory drugs, which can also be used to treat testosterone deficiency. For instance, at ENDO 2018, which is the Endocrine Society's annual meeting, Dr. Fahim Ebrahimi presented the results of a recent study that analyzed the therapeutic effects of Anakinra on testosterone levels of individuals with metabolic syndrome. Therefore, such therapeutic approaches are expected to contribute to the growth of the market.

“Apart from the initiatives taken to increase awareness on disease among the population, and the rise in novel therapeutic approaches, factors such as the growing patient assistance programs and the rising chronic diseases are expected to impact the growth of the testosterone replacement therapy market during the forecast period” says a senior analyst at Technavio for research on pharmaceuticals, biotechnology, and life sciences.

Global testosterone replacement therapy market: Segmentation analysis

This market research report segments the global testosterone replacement therapy market by product (injections and topicals) and geographical regions (APAC, EMEA, and the Americas).

The Americas led the market in 2018 with a market share of over 43%, followed by EMEA and APAC respectively. The Americas region will continue to dominate the market and gain the highest incremental growth during the forecast period.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005655/en/

Business Wire
www.businesswire.com

Last updated on: 11/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.